Cognitive Behavioral Therapy Improves Treatment Outcomes for Prescription Opioid Users in Primary Care Buprenorphine Treatment

Brent A. Moore; David A. Fiellin; Christopher J. Cutter; Frank D. Buono; Declan T. Barry; Lynn E. Fiellin; Patrick G. O'Connor; Richard S. Schottenfeld

doi:10.1016/j.jsat.2016.08.016

journal article Dec 01, 2016

Cognitive Behavioral Therapy Improves Treatment Outcomes for Prescription Opioid Users in Primary Care Buprenorphine Treatment

Brent A. Moore David A. Fiellin

Christopher J. Cutter Frank D. Buono Declan T. Barry Lynn E. Fiellin Patrick G. O'Connor Richard S. Schottenfeld

Journal of Substance Abuse Treatment Vol. 71 pp. 54-57 · Elsevier BV

View at Publisher Save 10.1016/j.jsat.2016.08.016

Topics

No keywords indexed for this article. Browse by subject →

References

27

[1]

Amato "Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence" Cochrane Database of Systematic Reviews (2011)

[2]

Banta-Green "Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users" Addiction (2009) 10.1111/j.1360-0443.2009.02538.x

[3]

The empirical status of cognitive-behavioral therapy: A review of meta-analyses

Andrew C. Butler, Jason E. Chapman, Evan M. Forman et al.

Clinical Psychology Review 2006 10.1016/j.cpr.2005.07.003

[4]

Carroll "Computer-assisted delivery of cognitive-behavioral therapy: Efficacy and durability of CBT4CBT among cocaine-dependent individuals maintained on methadone" American Journal of Psychiatry (2014) 10.1176/appi.ajp.2013.13070987

[5]

Center for Behavioral Health Statistics and Quality

[6]

Cleland "Age differences in heroin and prescription opioid abuse among enrolees into opioid treatment programs" Substance Abuse Treatment, Prevention, and Policy (2011) 10.1186/1747-597x-6-11

[7]

Drummond Drugs: Education, Prevention and Policy (2005)

[8]

Fals-Stewart "The timeline followback reports of psychoactive substance use by drug-abusing patients: Psychometric properties" Journal of Consulting and Clinical Psychology (2000) 10.1037/0022-006x.68.1.134

[9]

Fiellin "A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine" American Journal of Medicine (2013) 10.1016/j.amjmed.2012.07.005

[10]

Hofmann "Cognitive-behavioral therapy for adult anxiety disorders: A meta-analysis of randomized placebo-controlled trials" Journal of Clinical Psychiatry (2008) 10.4088/jcp.v69n0415

[11]

Jones "Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers—United States, 2002–2004 and 2008–2010" Drug and Alcohol Dependence (2013) 10.1016/j.drugalcdep.2013.01.007

[12]

Ling "Comparison of behavioral treatment conditions in buprenorphine maintenance" Addiction (2013) 10.1111/add.12266

[13]

Marsch "Web-based behavioral treatment for substance use disorders as a partial replacement of standard methadone maintenance treatment" Journal of Substance Abuse Treatment (2014) 10.1016/j.jsat.2013.08.012

[14]

McHugh "Cognitive behavioral therapy for substance use disorders" Psychiatric Clinics of North America (2010) 10.1016/j.psc.2010.04.012

[15]

McLellan "The fifth edition of the Addiction Severity Index" Journal of Substance Abuse Treatment (1992) 10.1016/0740-5472(92)90062-s

[16]

Moore "Counseling and directly observed medication for primary care buprenorphine maintenance: A pilot study" Journal of Addiction Medicine (2012) 10.1097/adm.0b013e3182596492

[17]

Moore "The recovery line: A pilot trial of automated, telephone-based treatment for continued drug use in methadone maintenance" Journal of Substance Abuse Treatment (2013) 10.1016/j.jsat.2012.12.011

[18]

Moore "Primary care office-based buprenorphine treatment: Comparison of heroin and prescription opioid dependent patients" Journal of General Internal Medicine (2007) 10.1007/s11606-007-0129-0

[19]

Nielsen "A comparison of buprenorphine taper outcomes between prescription opioid and heroin users" Journal of Addiction Medicine (2013) 10.1097/adm.0b013e318277e92e

[20]

Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin, and Combined Users: Findings From Starting Treatment With Agonist Replacement Therapies (START)

Jennifer S. Potter, Elise N. Marino, Maureen P. Hillhouse et al.

Journal of Studies on Alcohol and Drugs 2013 10.15288/jsad.2013.74.605

[21]

Rosenblum "Prescription opioid abuse among enrollees into methadone maintenance treatment" Drug and Alcohol Dependence (2007) 10.1016/j.drugalcdep.2007.02.012

[22]

Sigmon "Characterizing the emerging population of prescription opioid abusers" American Journal on Addiction (2006) 10.1080/10550490600625624

[23]

Sobell "Reliability of a timeline method: Assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations" British Journal of Addiction (1988) 10.1111/j.1360-0443.1988.tb00485.x

[24]

Soeffing "Buprenorphine maintenance treatment in a primary care setting: outcomes at 1year" Journal of Substance Abuse Treatment (2009) 10.1016/j.jsat.2009.05.003

[25]

Tetrault "Non-medical prescription opioid use and prescription opioid use disorder: A review" Yale Journal of Biological Medicine (2015)

[26]

Woody "Twelve-month follow-up of psychotherapy for opiate dependence" American Journal of Psychiatry (1987)

[27]

Wu "How do prescription opioid users differ from users of heroin or other drugs in psychopathology: Results from the National Epidemiologic Survey on Alcohol and Related Conditions" Journal of Addiction Medicine (2011) 10.1097/adm.0b013e3181e0364e

Cited By

60

Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention

Nora D. Volkow, Carlos Blanco · 2023

World Psychiatry

Metrics

60

Citations

27

References

Details

Published: Dec 01, 2016
Vol/Issue: 71
Pages: 54-57
License: View

Authors

B

Brent A. Moore

Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut

D

David A. Fiellin

Department of Internal Medicine, Yale University School of Medicine, New Haven, CT; and

C

Christopher J. Cutter

Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut

Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut

Richard S. Schottenfeld

Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut

Funding

National Institute on Drug Abuse Award: RO1 DA019511

Cite This Article

Brent A. Moore, David A. Fiellin, Christopher J. Cutter, et al. (2016). Cognitive Behavioral Therapy Improves Treatment Outcomes for Prescription Opioid Users in Primary Care Buprenorphine Treatment. Journal of Substance Abuse Treatment, 71, 54-57. https://doi.org/10.1016/j.jsat.2016.08.016

Cognitive Behavioral Therapy Improves Treatment Outcomes for Prescription Opioid Users in Primary Care Buprenorphine Treatment

You May Also Like